Viatris (Mylan, INC)

Generics and specialty pharmaceutical company

Based in PA

🤖

AI Overview

With $340K in lobbying spend across 7 quarterly filings, Viatris (Mylan, INC) is an active lobbying client. Their lobbying covers 2 issue areas.

$340K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2025	$340K

Issues Lobbied

Health Issues Copyright/Patent

Lobbying Firms

S-3 Group

Lobbyists

Ashley Davis Kristi Remington Shimon Stein Malloy Mcdaniel Christopher Buki

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Copyright/Patent

•Issues related to drug pricing; pharmaceutical supply chain; modernizational of prescribing information for physicians and pharmacists; Increasing Trasnparency in Generic Drug Applications, S.1302 and

•Issues related to drug pricing; pharmaceutical supply chain; modernization of prescribing information for physicians and pharmacists; Increasing Transparency in Generic Drug Applications, S.1302 and H

•Issues related to patent policy and reform, including to address patent thickets and FDA/PTO Coordination; S.527 Prescription Pricing for the People Act; S.1096 Preserve Access to Affordable Generics